FN3K expression in COPD: a potential comorbidity factor for cardiovascular disease.

Amr AlderawiGaetano CaramoriEmma H BakerAndrew William HitchingsIrfan RahmanChristos RossiosIan AdcockPaolo CassolariAlberto PapiVictor E OrtegaJeffrey L CurtisSimon DunmorePaul Kirkham

Published in: BMJ open respiratory research (2021)

The data highlight that low and high FN3K expressors exist within our study cohort and metformin induces FN3K levels, highlighting a potential mechanism to reduce the risk of CVD comorbidity and mortality.

Keyphrases

cardiovascular disease
poor prognosis
chronic obstructive pulmonary disease
cardiovascular events
type diabetes
human health
metabolic syndrome
cardiovascular risk factors
air pollution